Pharvaris N.V. Research And Development Expense

Quick Answer

Pharvaris N.V. reported Research And Development Expense of $98.56 million for the year ending 2024.

  • Pharvaris N.V. showed an increase of +50.3% in Research And Development Expense from 2023 to 2024.
  • This data is from Pharvaris N.V.'s annual report (Form 10-K), filed with the SEC on April 7, 2025.
  • XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2018 to 2024), Pharvaris N.V.'s Research And Development Expense has grown by 2,603.8%.
  • Historical annual values: Fiscal year 2024: $98.56 million | Fiscal year 2023: $65.58 million | Fiscal year 2022: $57.38 million | Fiscal year 2021: $35.79 million | Fiscal year 2020: $19.51 million | Fiscal year 2019: $5.68 million | Fiscal year 2018: $3.65 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: